ADC Therapeutics SA
ADCT
$3.10
-$0.01-0.32%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -169.94M | -149.84M | -157.85M | -212.15M | -214.91M |
| Total Depreciation and Amortization | 3.24M | 3.23M | 3.28M | 3.33M | 3.41M |
| Total Amortization of Deferred Charges | 800.00K | 590.00K | 902.00K | 2.15M | 2.46M |
| Total Other Non-Cash Items | 34.19M | 25.71M | 26.01M | 72.45M | 72.20M |
| Change in Net Operating Assets | 4.40M | -15.77M | 3.83M | 601.00K | -8.40M |
| Cash from Operations | -127.32M | -136.07M | -123.84M | -133.62M | -145.25M |
| Capital Expenditure | -570.00K | -600.00K | -867.00K | -1.10M | -1.55M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -570.00K | -600.00K | -867.00K | -1.10M | -1.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 94.35M | 99.01M | 99.10M | 99.05M | 99.40M |
| Repurchase of Common Stock | -2.29M | -2.04M | -2.04M | -880.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 92.06M | 96.97M | 97.05M | 98.17M | 99.40M |
| Foreign Exchange rate Adjustments | 272.00K | 121.00K | -83.00K | 412.00K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.56M | -39.58M | -27.73M | -36.14M | -47.39M |